StonvexLoading…
StonvexStonvexStonvexCore line items from VIAV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-28 | Annual 2024 2024-06-29 | Annual 2023 2023-07-01 | Annual 2023 2023-04-01 |
|---|---|---|---|---|
Revenue | $1.08B | $1.00B | $1.11B | $247.80M |
Operating Income | $57.50M | $20.80M | $82.40M | Not available |
Net Income | $34.80M | $-25.80M | $25.50M | $-15.40M |
EPS (Diluted) | $0.15 | $-0.12 | $0.11 | $-0.07 |
Total Assets | $1.99B | $1.74B | $1.85B | Not available |
Total Liabilities | $1.21B | $1.05B | Not available | Not available |
Cash & Equivalents | $423.60M | $471.30M | $506.50M | Not available |
Free Cash Flow OCF − CapEx | $62.00M | $96.90M | $63.00M | Not available |
Shares Outstanding | 223.00M | 222.00M | 222.00M | 224.10M |